Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jan;225(1):184-190.
doi: 10.1016/j.amjsurg.2022.07.023. Epub 2022 Jul 31.

Factors that influence discharge opioid prescribing among bariatric surgeons across Michigan

Affiliations

Factors that influence discharge opioid prescribing among bariatric surgeons across Michigan

C Ann Vitous et al. Am J Surg. 2023 Jan.

Abstract

Background: Opioid prescribing following bariatric surgery has been a focus due to its association with new persistent opioid use (NPOU) and worse outcomes. Guidelines have led to a reduction in opioids prescribed, but there remains variation in prescribing practices.

Methods: We conducted interviews with 20 bariatric surgeons across Michigan. Transcripts were analyzed using descriptive content analysis.

Results: At the patient level, surgeons described the role of surgical history and pain tolerance. At the provider level, surgeons discussed patient dissatisfaction, reputation, and workload. At the institution level, surgeons discussed colleagues, resources, and administration. At a collaborative level, surgeons described the role of evidence and performance measures. There was lack of consensus on whether NPOU is a problem facing patients undergoing bariatric surgery.

Conclusion: Despite efforts aimed at addressing opioid prescribing, variability exists in prescribing practices. Understanding determinants that impact stakeholder alignment is critical to increasing adherence to guideline-concordant care.

Keywords: Bariatric surgery; New persistent opioid use; opioid Prescribing.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest No conflicts of interest, use of off-label or unapproved drugs or products, or use of previously copyrighted material.

Substances

LinkOut - more resources